PF-AtlasDrugs › Liver Fibrosis Reversal Protocol Crossover

Liver Fibrosis Reversal Protocol Crossover

Idiopathic Pulmonary Fibrosis · Applying proven liver fibrosis reversal mechanisms to lung — stellate cell parallels to myofibroblast

Mechanism
Applying proven liver fibrosis reversal mechanisms to lung — stellate cell parallels to myofibroblast
Development stage
Translational
Evidence level
Level 2 (Cross-domain)
Developer
Icahn Sinai / Multiple

Overview

Liver fibrosis is REVERSIBLE in humans when cause removed. Hepatic stellate cells = lung myofibroblasts. Same TGF-β/PDGF/Hedgehog pathways. Key insight: liver achieves reversal through matrix metalloproteinase activation + stellate cell apoptosis. Apply MMP activation strategy to lung.

Explore related

Medical disclaimer. This page summarizes research about Liver Fibrosis Reversal Protocol Crossover for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.